6533b85efe1ef96bd12bfdc0

RESEARCH PRODUCT

Exosomes as mediators of neuron-glia communication in neuroinflammation

Consuelo GuerriMaría PascualFrancesc Ibáñez

subject

0301 basic medicinemedia_common.quotation_subjectCentral nervous systemneuronsReviewexosomesBiologyExosomelcsh:RC346-429neuroinflammationPathogenesis03 medical and health sciences0302 clinical medicineDevelopmental NeuroscienceBystander effectmedicineInternalizationNeuroinflammationlcsh:Neurology. Diseases of the nervous systemmedia_commonbiomarkers; exosomes; glial cells; neuroinflammation; neuron-glia commuication; neurons; neuropathology; therapyneuropathologytherapyneuron-glia commuicationbiomarkersMicrovesiclesglial cells030104 developmental biologymedicine.anatomical_structureNeuronNeuroscience030217 neurology & neurosurgery

description

In recent years, a type of extracellular vesicles named exosomes has emerged that play an important role in intercellular communication under physiological and pathological conditions. These nanovesicles (30–150 nm) contain proteins, RNAs and lipids, and their internalization by bystander cells could alter their normal functions. This review focuses on recent knowledge about exosomes as messengers of neuron-glia communication and their participation in the physiological and pathological functions in the central nervous system. Special emphasis is placed on the role of exosomes under toxic or pathological stimuli within the brain, in which the glial exosomes containing inflammatory molecules are able to communicate with neurons and contribute to the pathogenesis of neuroinflammation and neurodegenerative disorders. Given the small size and characteristics of exosomes, they can cross the blood-brain barrier and be used as biomarkers and diagnosis for brain disorders and neuropathologies. Finally, although the application potential of exosome is still limited, current studies indicate that exosomes represent a promising strategy to gain pathogenic information to identify therapeutically targets and biomarkers for neurological disorders and neuroinflammation.

10.4103/1673-5374.268893http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=5;spage=796;epage=801;aulast=Pascual